PCMA

Removing DIR Fees Could Save Billions
Removing DIR Fees Could Save BillionsA study commissioned by the NCPA shows the effect of DIR fees.
New Report: PBMs Push Drug Costs
New Report: PBMs Push Drug CostsAre PBMs responsible for higher drug prices or is something else to blame?
Patients, payers, and manufacturers’ drug couponsAccording to PBMs, those drug coupons are something else.
Are your prior auth provisions stifling medication adherence?Prior authorizations are here to stay. Are yours working against you? Find out.
Will PCMA proposal for Rx savings materialize?The Pharmaceutical Care Management Association is urging Congress to consider a series of policies it believes would save $100 billion in federal prescription drug spending and improve safety in Medicare and Medicaid.
BOPs don’t protect pharmacistsVoices-Letters to the Editor
PCMA’s plan to curb Rx drug abuse, Medicare fraudThe Pharmaceutical Care Management Association has asked Congress to consider policy changes it believes will reduce prescription drug abuse and Medicare fraud.
Voices 06-15-2013Drug Topics readers weigh in